# Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sintilimab-plus-chemotherapy-for-patients-with-egfr-mutated-non-squamous-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shun Lü,Lin Wu,Hong Jian,Ying Cheng,Qiming Wang,Jian Fang,Ziping Wang,Yanping Hu,Liang Han,Meili Sun,Liyun Miao,Cuimin Ding,Jiuwei Cui,Ke Wang,Baolan Li,Xingya Li,Feng Ye,Anwen Liu,Yueyin Pan,Shundong Cang,Hui Zhou,Xing Sun,Yuping Shen,Shuyan Wang,Wen Zhang,Yue He |
| Citations | 208 |
| DOI | 10.1016/s2213-2600(23)00135-2 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4372214946 |
| PMID | 37156249 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Lin Wu](https://scholariq.org/researchers/lin-wu/)
- [Ke Wang](https://scholariq.org/researchers/ke-wang/)
- [Hong Jian](https://scholariq.org/researchers/hong-jian/)

## Paper journal

- [The Lancet Respiratory Medicine](https://scholariq.org/journals/the-lancet-respiratory-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.